Home / Fact sheets / Czechia / Cervical quantitative data
Country fact sheet: Czechia (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 0 | |
Population (not personally invited) | ||||||||||||||
Target population | 322990 | 345133 | 394481 | 455538 | 362606 | 347406 | 314690 | 371869 | 384522 | 345652 | 240725 | 182793 | 0 | 4 068 405 |
Annual target population | 322 990 | 345 133 | 394 481 | 455 538 | 362 606 | 347 406 | 314 690 | 371 869 | 384 522 | 345 652 | 240 725 | 182 793 | 0 | 4 068 405 |
Women screened | 198 199 | 215 861 | 240 039 | 279 006 | 218 700 | 190 614 | 153 209 | 157 594 | 150 710 | 123 379 | 68 274 | 32 374 | 0 | 2 027 959 |
Examination coverage rate (%) | 61.4 | 62.5 | 60.8 | 61.2 | 60.3 | 54.9 | 48.7 | 42.4 | 39.2 | 35.7 | 28.4 | 17.7 | 0.0 | 49.8 |
Result (All tests in the year) | ||||||||||||||
Positive | 3 922 | 4 615 | 4 075 | 4 176 | 2 900 | 2 168 | 1 209 | 765 | 566 | 478 | 304 | 127 | 0 | 25 305 |
Negative | 194 277 | 211 246 | 235 964 | 274 830 | 215 800 | 188 446 | 152 000 | 156 829 | 150 144 | 122 901 | 67 970 | 32 247 | 0 | 2 002 654 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 2.0 | 2.1 | 1.7 | 1.5 | 1.3 | 1.1 | 0.8 | 0.5 | 0.4 | 0.4 | 0.2 | 0.1 | 0.0 | 1.2 |
Further assessment (all positive) | ||||||||||||||
Done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Not done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 3 922 | 4 615 | 4 075 | 4 176 | 2 900 | 2 168 | 1 209 | 765 | 566 | 478 | 304 | 127 | 0 | 25 305 |
Further assessment participation rate (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 240 | 298 | 335 | 396 | 360 | 278 | 172 | 100 | 77 | 56 | 38 | 12 | 0 | 2 362 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 11 | 10 | 8 | 12 | 3 | 15 | 11 | 4 | 1 | 5 | 3 | 0 | 0 | 83 |
Carcinoma | 1 | 11 | 17 | 30 | 20 | 18 | 16 | 25 | 20 | 26 | 19 | 8 | 0 | 211 |
CIN3 / Adenocarcinoma in situ (CGIN) | 349 | 603 | 561 | 545 | 286 | 155 | 60 | 57 | 48 | 42 | 22 | 11 | 0 | 2 739 |
CIN2 | 192 | 288 | 246 | 228 | 120 | 80 | 39 | 12 | 10 | 8 | 13 | 3 | 0 | 1 239 |
CIN1 | 208 | 204 | 178 | 201 | 148 | 100 | 44 | 16 | 19 | 9 | 8 | 3 | 0 | 1 138 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | -1 001 | -1 414 | -1 345 | -1 412 | -937 | -646 | -342 | -214 | -175 | -146 | -103 | -37 | 0 | -7 772 |